Baseline demographic and clinical characteristics by CD25 expression in the 396 patients with detailed mutational analysis
| . | CD25NEG (n = 316) . | CD25POS (n = 80) . | P . |
|---|---|---|---|
| Age, y | 47 (18-60) | 46 (18-60) | .39 |
| WBC, 1000/mm3 | 18.5 (0.6-212.8) | 24.8 (1.0-181.0) | .03 |
| Hemoglobin, g/dL | 9.2 (5-30) | 9.2 (5-11.7) | .51 |
| Peripheral blasts, % | 45 (0-98) | 52.5 (0-92) | .55 |
| Platelets, 1000/mm3 | 51 (0.7-650) | 48 (1.4-261) | .54 |
| Marrow blast | 68 (3-100) | 65 (8-99) | .61 |
| Female sex, no. patients, % | 146 (46) | 43 (54) | .26 |
| Cytogenetics favorable, no. patients, % | 67 (23) | 4 (5) | < .001 |
| Cytogenetics intermediate, no. patients, % | 171 (58) | 63 (85) | |
| Cytogenetics unfavorable, no. patients, % | 59 (20) | 7 (10) |
| . | CD25NEG (n = 316) . | CD25POS (n = 80) . | P . |
|---|---|---|---|
| Age, y | 47 (18-60) | 46 (18-60) | .39 |
| WBC, 1000/mm3 | 18.5 (0.6-212.8) | 24.8 (1.0-181.0) | .03 |
| Hemoglobin, g/dL | 9.2 (5-30) | 9.2 (5-11.7) | .51 |
| Peripheral blasts, % | 45 (0-98) | 52.5 (0-92) | .55 |
| Platelets, 1000/mm3 | 51 (0.7-650) | 48 (1.4-261) | .54 |
| Marrow blast | 68 (3-100) | 65 (8-99) | .61 |
| Female sex, no. patients, % | 146 (46) | 43 (54) | .26 |
| Cytogenetics favorable, no. patients, % | 67 (23) | 4 (5) | < .001 |
| Cytogenetics intermediate, no. patients, % | 171 (58) | 63 (85) | |
| Cytogenetics unfavorable, no. patients, % | 59 (20) | 7 (10) |
All values are median (range) unless otherwise noted.
AML indicates acute myeloid leukemia; and WBC, white blood cell count.